Drägerwerk AG & Co. KGaA

Research Drägerwerk AG & Co. KGaA (DRW8) on Bullrun: valuation model: 63.9% undervalued, market cap EUR 1.34B, P/E 8.7, dividend yield 3.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDRW8
• ExchangeXETRA
• CountryGermany
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Valuation signal63.9% undervalued
• Market capEUR 1.34B
• P/E8.7
• Dividend yield3.2%
• Financial periodQ4 2025
• RevenueEUR 1.14B
• Net incomeEUR 94.65M
• Free cash flowEUR 113.15M
• Gross margin45.5%

Valuation Snapshot

Bullrun's latest valuation model marks Drägerwerk AG & Co. KGaA as 63.9% undervalued; latest market cap is EUR 1.34B; P/E is 8.7; dividend yield is 3.2%.

About Drägerwerk AG & Co. KGaA

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine.

Frequently asked questions

Is Drägerwerk AG & Co. KGaA overvalued or undervalued?

Bullrun's valuation model currently marks Drägerwerk AG & Co. KGaA as 63.9% undervalued.

What is Drägerwerk AG & Co. KGaA's market cap?

Drägerwerk AG & Co. KGaA's market capitalization is EUR 1.34B.

What is Drägerwerk AG & Co. KGaA's P/E ratio?

Drägerwerk AG & Co. KGaA's price-to-earnings (P/E) ratio is 8.7.

Does Drägerwerk AG & Co. KGaA pay a dividend?

Drägerwerk AG & Co. KGaA has a dividend yield of 3.2%.

What does Drägerwerk AG & Co. KGaA do?

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine.